How CRISPR technology can solve our COVID-19 testing problems
To contain COVID-19 and re-open the economy, the U.S. should be performing 500,000 tests per day. We are nowhere near that number.
Widespread implementation of CRISPR-based testing would address deficits in the current testing landscape. The most common method of testing for COVID-19—reverse transcription-polymerase chain reaction (RT-PCR)—costs $100 per test, takes four-six hours to run, involves Read more…
